Evidence map›Paper›PMID 37507509›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

A unique role for cAMP signaling in microglia during opioid tolerance and withdrawal.

Kevin R Coffey, John F Neumaier

Open access · greenAbstract readNews
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kevin R CoffeyDepartment of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98105, USA.
John F NeumaierDepartment of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98105, USA. neumaier@uw.edu.ORCID 0000-0002-1763-7118
University of Washington · US

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Integrative single-cell spatial transcriptomic, anatomical, and functional profiling of brain-wide ensembles engaged by opioid relapseR01DA059374 · NIDA · UNIVERSITY OF WASHINGTON · PI Sam Golden, Liangcai Gu · 2023 to 2026
$3.1M
Microglia and Opioid Withdrawal: Mechanisms of Negative ReinforcementR01DA052618 · NIDA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI NEUMAIER, JOHN F · 2021 to 2025
$1.9M
Determining if Activity in Specific Lateral Habenula Output Pathways Motivates Avoidance of Synthetic Opioid Withdrawal or Cue Induced ReinstatementK99DA052571 · NIDA · UNIVERSITY OF WASHINGTON · PI COFFEY, KEVIN R. · 2021 to 2022
$349k
NIDA NIH HHS K99 DA052571NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA052618NIDA NIH HHS R01 DA059374
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Analgesics, OpioidSubstance Withdrawal SyndromeDrug ToleranceHumansMicrogliaMorphineReceptors, Opioid, muSignal TransductionAnalgesics, OpioidMorphineReceptors, Opioid, mu

Identifiers

PMID37507509
PMCPMC10700564
OpenAlexW4385342141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.